DHR241122C222500
- 0.00
- 0.000.00%
Danaher Newsroom
SA Charts: These S&P 500 Companies Spent the Largest on Buybacks Last Quarter
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Danaher Corporation (DHR) Highlighted Milestones in Its 2024 Corporate Sustainability Report
New DHR Global Report Reveals Burnout Having Little Impact On Employee Engagement
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
What the Options Market Tells Us About Danaher
Danaher Shares Are Trading Lower After Third Point in a 13F Disclosed That It Decreased Its Stake in the Company by 5%
Least Shorted S&P 500 Stocks in October
DiamondRock Hospitality Acquires the AC Hotel Minneapolis Downtown
Danaher Unit Cepheid Reportedly Urged to Cut Mpox Test Prices for Better Access
Third Point 13F Shows Decreased Stake In PG&E Corp By 7% From 53,750,000 To 49,750,000 Shares; Amazon By 27% From 5,100,000 To 3,700,000 Shares; Danaher Corp By 5% From 2,050,000 To 1,950,000 Shares; Vistra Corp By 29% From 4,470,000 To 3,175,000...
Possible Bearish Signals With Danaher Insiders Disposing Stock
Wells Fargo's 'Focus List' – GOOGL, TJX, XOM, JPM
Unusual Options Activity: SIRI, PINS and Others Attract Market Bets, SIRI V/OI Ratio Reaches 35.2
EST Nov 5th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Form 144 | Danaher(DHR.US) Insider Proposes to Sell 24.78 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 5, $Danaher(DHR.US)$ Insider Glenstone Foundation intends to sell 100K shares of its common stock on Nov 5, with a total market value of approximately $24.78 million.
Express News | Vice Chairman Li Qingshuang of the China Council for the Promotion of International Trade met with Chris Lalli, Executive Vice President and Chief Executive Officer of Danaher Group, USA.
Peering Into Danaher's Recent Short Interest
Inquiry Into Danaher's Competitor Dynamics In Life Sciences Tools & Services Industry
Wolfe Research Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $285